Skip to main content
TipRanks
Go Ultimate75% OFF

Joseph L. Turner Insider Profile

4 Followers

Joseph L. Turner, Director at Arcutis Biotherapeutics, holds 4.31K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 10.50K shares in Alexza Pharmaceuticals (Ticker: ALXA), holds 0.00 shares in Kythera (Ticker: KYTH).

Joseph L. Turner's Trading History

ARQT
Arcutis Biotherapeutics
Jun 03, 2022DirectorUninformative Buy―$117.07K
ALXA
Alexza Pharmaceuticals
Jun 21, 2016―Uninformative Sell―$9.82K
KYTH
Kythera
Oct 02, 2015―Uninformative Sell―$0.00
CORT
Corcept Therapeutics
Mar 14, 2013DirectorInformative Buy20.00K$692.20K
NVLNF
Novelion Therapeutics
―――$0.00
SPHS
Sophiris Bio
―――$0.00
VRDN
Viridian Therapeutics
―Director――

You May Also Like

Joseph L. Turner insider profile FAQ

What stocks does Joseph L. Turner hold?
Joseph L. Turner holds: ARQT, CORT, VRDN, ALXA, KYTH, SPHS, NVLNF stocks.
What was Joseph L. Turner's most profitable transaction?
Joseph L. Turner’s most profitable transaction was an Informative Buy of CORT stock on March 14, 2013. The return on the trade was 87.00%.
What is Joseph L. Turner's role in Arcutis Biotherapeutics?
Joseph L. Turner's role in Arcutis Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.